Lambros Chrones

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies

David S. Baldwin, Lambros Chrones, Ioana Florea et al. · Journal of Psychopharmacology · 2016 · 190 citations · Full text

Medicine, Pharmacology, Psychiatry +15

Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction

Paula L. Jacobsen, Atul R. Mahableshwarkar, Y. Chen et al. · The Journal of Sexual Medicine · 2015 · 117 citations

Medicine, Pharmacology, Psychiatry +12

Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder

Paula L. Jacobsen, Linda Harper, Lambros Chrones et al. · International Clinical Psychopharmacology · 2015 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor

Max Tsai, Lambros Chrones, Jinhui Xie et al. · Psychopharmacology · 2016 · 21 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis

Anne Kangethe, Debra Lawrence, Maëlys Touya et al. · BMC Health Services Research · 2021 · 21 citations · Full text

Education, Internal Medicine, Pharmacoeconomics +17